Activation of the PI3K/protein kinase B (Akt) pathway leads to the upregulated expression of XIAP, which modulates death signaling pathways and is a determinant of cisplatin resistance in ovarian cancer cells. The gene discussed is AKT1; the disease is ovarian carcinoma.